Fig. 7From: Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathwayImmunological differences between high- and low-THBS2-expression groups. A KM curves demonstrating PFI in the high- and low-THBS2-expression groups; B: Heat map demonstrating the differential expression of immunomodulators between the high- and low-THBS2-expression groups; C Box plot demonstrating differences in the proportion of 28 types of tumour-infiltrating immune cells between the two THBS2 groups; D–G Box plots demonstrating differences in the four types of scores between the two THBS2 groups as evaluated using the ESTIMATE algorithm; H Heat map of similarity between the high- and low-THBS2-expression groups and immunotherapy response groups (with and without response subgroups) obtained from SubMap analysis; I, J Violin plots demonstrating differences in IPSs between the high- and low-THBS2-expression groupsBack to article page